1.04

0.97% 0.01

Cytosorbents Corp (CTSO)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Perché CTSO Giù? Forum Previsione Frazionamento azionario

Precedente Chiudi:

$1.03

Aprire:

$1.02

Volume 24 ore:

23,627

Relative Volume:

0.21

Capitalizzazione di mercato:

$65.11M

Reddito:

$33.79M

Utile/perdita netta:

$-18.67M

Rapporto P/E:

-2.9034

EPS:

-0.3582

Flusso di cassa netto:

$-19.17M

1 W Prestazione:

-0.95%

1M Prestazione:

-11.86%

6M Prestazione:

+0.00%

1 anno Prestazione:

-0.95%

Intervallo 1D:

$1.01

$1.05

Intervallo di 1 settimana:

$0.99

$1.10

Portata 52W:

$0.7101

$1.61

Cytosorbents Corp Stock (CTSO) Company Profile

Nome

Cytosorbents Corp

Settore

Healthcare (1161)

Industria

Medical Devices (147)

Telefono

973-329-8885

Indirizzo

305 COLLEGE ROAD EAST, PRINCETON, NJ

Dipendente

149

Cinguettio

@CytoSorbents

Prossima data di guadagno

2025-03-31

Ultimi documenti SEC

CTSO's Discussions on Twitter

Confronta CTSO con altri titoli

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
CTSO Cytosorbents Corp	1.04	65.74M	33.79M	-18.67M	-19.17M	-0.3582
ABT Abbott Laboratories	124.42	229.71B	43.11B	13.98B	6.66B	7.98
BSX Boston Scientific Corp	103.78	154.35B	17.55B	2.03B	2.72B	1.37
SYK Stryker Corp	387.32	149.60B	23.22B	2.86B	3.58B	7.40
MDT Medtronic Plc	89.70	114.97B	33.54B	4.66B	5.19B	3.62
EW Edwards Lifesciences Corp	76.56	45.92B	5.54B	4.18B	623.10M	7.00

Cytosorbents Corp Stock (CTSO) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2023-09-07	Iniziato	B. Riley Securities	Buy
2021-10-14	Ripresa	B. Riley Securities	Buy
2020-09-17	Iniziato	Jefferies	Buy
2020-09-01	Iniziato	SVB Leerink	Outperform
2017-08-08	Reiterato	Maxim Group	Buy
2016-10-26	Iniziato	Aegis Capital	Buy
2016-05-24	Iniziato	Maxim Group	Buy
2015-10-29	Aggiornamento	WBB Securities	Speculative Buy → Buy
2015-05-12	Reiterato	MLV & Co	Buy
2015-04-01	Reiterato	MLV & Co	Buy
2015-03-05	Iniziato	MLV & Co	Buy
2015-02-25	Iniziato	WBB Securities	Speculative Buy
2015-01-27	Reiterato	H.C. Wainwright	Buy

Mostra tutto

Cytosorbents Corp Borsa (CTSO) Ultime notizie

02:20 AM

Cytosorbents (NASDAQ:CTSO) Given “Buy” Rating at D. Boral Capital - Defense World

02:20 AM

Jul 19, 2025

What analysts say about Cytosorbents Corporation stockExceptional risk-adjusted gains - jammulinksnews.com

Jul 19, 2025

Is Cytosorbents Corporation a good long term investmentExtraordinary profit generation - jammulinksnews.com

Jul 19, 2025

Jul 18, 2025

What drives Cytosorbents Corporation stock priceMassive wealth growth - jammulinksnews.com

Jul 18, 2025

What institutions are buying Cytosorbents Corporation stock nowLong Term Low Risk Growth - Newser

Jul 18, 2025

Jul 15, 2025

Why Cytosorbents Corporation stock attracts strong analyst attentionFree Access to Stock Community - Newser

Jul 15, 2025

What makes Cytosorbents Corporation stock price move sharplyRisk Controlled Trading Ideas - Newser

Jul 15, 2025

Jul 02, 2025

Cytosorbents stock plunges after regulatory setbacks for key device - Investing.com

Jul 02, 2025

CytoSorbents provides FDA, Health Canada regulatory update for DrugSorb-ATR - TipRanks

Jul 02, 2025

Cytosorbents Provides U.S. FDA And Health Canada Regulatory Update For Drugsorb-Atr - TradingView

Jul 02, 2025

CytoSorbents receives FDA appeal hearing date for DrugSorb-ATR device - Investing.com

Jul 02, 2025

CytoSorbents Provides U.S. FDA and Health Canada Regulatory Update for DrugSorb-ATR - PR Newswire

Jul 02, 2025

Jun 30, 2025

Cytosorbents Corporation(NasdaqCM: CTSO) added to Russell Microcap Index - MarketScreener

Jun 30, 2025

Jun 24, 2025

CytoSorbents files appeal with FDA over denied device application - Investing.com

Jun 24, 2025

Jun 23, 2025

CytoSorbents Q1 2025 slides: Revenue dips 3% as company targets breakeven by year-end - Investing.com

Jun 23, 2025

Jun 15, 2025

Millennium Management LLC Buys Shares of 33,280 Cytosorbents Co. (NASDAQ:CTSO) - Defense World

Jun 15, 2025

Jun 13, 2025

Cytosorbents announces voting results from annual meeting By Investing.com - Investing.com Canada

Jun 13, 2025

Cytosorbents announces voting results from annual meeting - Investing.com

Jun 13, 2025

Jun 11, 2025

CytoSorbents Warrants Expire Worthless as Stock Price Fails Threshold - Investing.com

Jun 11, 2025

Jun 04, 2025

Cytosorbents Co. (NASDAQ:CTSO) Shares Purchased by Northern Trust Corp - Defense World

Jun 04, 2025

May 29, 2025

Critical Care Leader CytoSorbents Reveals Growth Strategy at Jefferies Healthcare Conference - Stock Titan

May 29, 2025

May 22, 2025

Cytosorbents Therapy Significantly Reduces Bleeding in Urgent CABG Patients on Ticagrelor in New Data Presented At EuroPCR 2025 - marketscreener.com

May 22, 2025

CytoSorbents device cuts bleeding in CABG patients - Investing.com

May 22, 2025

New Clinical Data: How CytoSorbents' Breakthrough Device Slashes Severe Bleeding Risk in Urgent Heart Surgery - Stock Titan

May 22, 2025

May 21, 2025

Cytosorbents (NASDAQ:CTSO) Coverage Initiated by Analysts at StockNews.com - Defense World

May 21, 2025

May 19, 2025

Cytosorbents FY2025 EPS Forecast Lifted by HC Wainwright - Defense World

May 19, 2025

May 17, 2025

D. Boral Capital Reiterates “Buy” Rating for Cytosorbents (NASDAQ:CTSO) - Defense World

May 17, 2025

Cytosorbents (NASDAQ:CTSO) Earns Neutral Rating from HC Wainwright - Defense World

May 17, 2025

May 16, 2025

Cytosorbents Corporation (NASDAQ:CTSO) Q1 2025 Earnings Call Transcript - Insider Monkey

May 16, 2025

May 15, 2025

Cytosorbents Corp’s Earnings Call: A Balanced Outlook - TipRanks

May 15, 2025

CytoSorbents (CTSO) Receives Neutral Rating from HC Wainwright & Co. | CTSO Stock News - GuruFocus

May 15, 2025

CytoSorbents (CTSO) Maintains Buy Rating with $10 Price Target | - GuruFocus

May 15, 2025

CytoSorbents (CTSO) Maintains Buy Rating with $10 Price Target | CTSO Stock News - GuruFocus

May 15, 2025

CytoSorbents: Q1 Earnings Snapshot - CT Insider

May 15, 2025